Novo Nordisk is planning to lay off around 3,000 people from its global workforce. From the looks of it, US will be hit hard as US pricing uncertainties are the main reason for the incoming cuts.
https://endpts.com/diabetes-giant-novo-said-to-consider-up-to-3000-layoffs-as-growth-wanes-report/